Literature DB >> 9754818

No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise.

K F Eriksson1, F Lindgärde.   

Abstract

Impaired glucose tolerance (IGT) is associated with increased mortality due to ischaemic heart disease (IHD), but as it is not known whether this excess mortality can be reduced by preventing or delaying the development of non-insulin-dependent diabetes mellitus (NIDDM), a long-term NIDDM prevention trial of dietary counselling and physical exercise was launched at Malmö, Sweden, the 12-year follow-up of which is reported here. At 12-year follow-up of 6956 men who underwent health screening at 48 years of age, an IGT intervention group (n = 288) who participated in a long-term NIDDM prevention programme were compared with an IGT non-randomised routine treatment group (n = 135), a diabetic group (n = 144), and the remainder, the normal glucose tolerance (NGT) group (n = 6389). The variables studied included the levels of blood glucose, plasma insulin, blood pressure, blood lipids, lung function and maximum oxygen uptake. Subjects with IGT were characterised by overweight, poor vital capacity, hypertension, hypertriglyceridaemia and hyperinsulinaemia. The mortality rate in the IGT intervention group was similar to that in the NGT group (6.5 vs 6.2 per 1000 person years at risk) and lower than that in the IGT routine treatment group (6.5 vs 14.0, p = 0.009). In the two IGT groups taken together, intervention but not body mass index, systolic blood pressure, smoking, cholesterol or the 2-h glucose level predicted mortality. Systolic blood pressure was a predictor of IHD mortality among IGT subjects; and in the cohort as a whole, body mass index, systolic blood pressure, hypercholesterolaemica, diabetes and smoking were predictors of IHD mortality. The findings suggest that a long-term intervention programme, with an emphasis on lifestyle changes, including dietary counselling and physical exercise, will reduce mortality in subjects with IGT who are at an increased risk of both developing NIDDM and of premature death due to IHD and other causes.

Entities:  

Mesh:

Year:  1998        PMID: 9754818     DOI: 10.1007/s001250051024

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions.

Authors:  Graeme Wylie; A Pali S Hungin; Joanne Neely
Journal:  BMJ       Date:  2002-05-18

2.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

3.  The answer to diabetes prevention: science, surgery, service delivery, or social policy?

Authors:  Ruth Colagiuri; Stephen Colagiuri; Derek Yach; Stig Pramming
Journal:  Am J Public Health       Date:  2006-07-27       Impact factor: 9.308

4.  Low physical function as a risk factor for incident diabetes mellitus and insulin resistance.

Authors:  Allison Longenberger; Jeong Youn Lim; Todd T Brown; Alison Abraham; Frank J Palella; Rita B Effros; Trevor Orchard; Maria Mori Brooks; Lawrence A Kingsley
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

5.  Changing behavioral patterns to promote physical activity with motivational signs.

Authors:  Takuo Nomura; Yoshinobu Yoshimoto; Yoshiteru Akezaki; Atushi Sato
Journal:  Environ Health Prev Med       Date:  2008-10-25       Impact factor: 3.674

Review 6.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

7.  Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes.

Authors:  D Tripathy; K F Eriksson; M Orho-Melander; J Fredriksson; G Ahlqvist; L Groop
Journal:  Diabetologia       Date:  2004-04-28       Impact factor: 10.122

8.  Diet, exercise and the metabolic syndrome.

Authors:  Christos Pitsavos; Demosthenes Panagiotakos; Michael Weinem; Christodoulos Stefanadis
Journal:  Rev Diabet Stud       Date:  2006-11-10

9.  Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.

Authors:  Matti Uusitupa; Markku Peltonen; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Timo T Valle; Johan G Eriksson; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

Review 10.  Nonpharmacologic therapy and exercise in the prevention of type 2 diabetes.

Authors:  Jaakko Tuomilehto
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.